Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

454.38
-13.1700-2.82%
Post-market: 453.38-1.0000-0.22%19:52 EDT
Volume:1.08M
Turnover:493.92M
Market Cap:59.56B
PE:-184.42
High:469.81
Open:469.17
Low:454.20
Close:467.55
52wk High:469.81
52wk Low:205.87
Shares:131.08M
Float Shares:126.15M
Volume Ratio:0.96
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4638
EPS(LYR):-2.1790
ROE:-257.82%
ROA:-2.63%
PB:237.68
PE(LYR):-208.52

Loading ...

Pushkal Garg, EVP Chief R&D, Reports Disposal of Common Shares of Alnylam Pharmaceuticals Inc

Reuters
·
Aug 20

Tolga Tanguler, EVP and Chief Commercial Officer, Reports Disposal of Common Shares of Alnylam Pharmaceuticals Inc

Reuters
·
Aug 20

Director Michael W. Bonney Reports Disposal of Common Shares in Alnylam Pharmaceuticals Inc

Reuters
·
Aug 20

Three Companies That Might Be Priced Below Their Estimated Value

Simply Wall St.
·
Aug 19

Private Credit Is a Booming Business. Where One Pro Sees Risks and Opportunities Now. -- Barrons.com

Dow Jones
·
Aug 15

Alnylam Pharmaceuticals Unveils Promising New Data from Hypertension and ATTR Program Trials at ESC Congress 2025

Reuters
·
Aug 11

Alnylam Pharmaceuticals (ALNY) Is Up 9.2% After Upward Q2 Revenue Guidance Revision and Higher Analyst Forecasts—Has the Bull Case Changed?

Simply Wall St.
·
Aug 11

AI Play Arista Hits Record High, Joins 3 Best Stock Lists: Build Your Growth Stock Watchlist With These Just Updated Screens

Blockhead
·
Aug 07

Alnylam Pharmaceuticals Is Maintained at Overweight by JP Morgan

Dow Jones
·
Aug 07

U.S. RESEARCH ROUNDUP-Allstate, BP, Oracle

Reuters
·
Aug 06

Alnylam Pharmaceuticals to Present at Canaccord Genuity 45th Annual Growth Conference

Reuters
·
Aug 05

Stock Track | Alnylam Pharmaceuticals Soars 5% as Oppenheimer Upgrades on Amvuttra's Strong Sales

Stock Track
·
Aug 05

Alnylam's Amvuttra Sales Exceeding Expectations by Sizable Margin, Oppenheimer Says

MT Newswires Live
·
Aug 04

Alnylam Pharmaceuticals Inc : Oppenheimer Raises to Outperform From Perform

THOMSON REUTERS
·
Aug 04

Wolfe Upgrades Alnylam Pharmaceuticals to Peer Perform From Underperform

MT Newswires Live
·
Aug 04

Stifel Nicolaus Remains a Buy on Alnylam Pharma (ALNY)

TIPRANKS
·
Aug 04

Weekly Winners | Figma Soars 270%; Reddit Surges 26%; eBay Jumps 13%; Carvana, Western Digital Rise 11%

Tiger Newspress
·
Aug 03

Alnylam Pharmaceuticals Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
Aug 02

Alnylam's Amvuttra Makes Powerful Entrance, Eyes First-Line Dominance

Benzinga
·
Aug 02

UBS Adjusts Price Target on Alnylam Pharmaceuticals to $550 From $403, Maintains Buy Rating

MT Newswires Live
·
Aug 01